The goal of this project is to study retail drug market characteristics and their relationship to drug use patterns, medical consequences of drug use and cross-border mobility among injection drug users (IDUs) in the southwestern U.S.-Mexico border region. Mexico is the largest foreign supplier of illicit drugs to the U.S. Tijuana, the sister city of San Diego, CA, is home to the busiest border crossing in the world and is situated on a major drug trafficking route whereby heroin, methamphetamine (meth) and cocaine have created thriving local consumption markets. Little is known about local trends in retail drug markets, their antecedents and impacts in this region, which has a bearing on both countries. We will leverage our existing binational research infrastructure to conduct surveillance of specific drug market characteristics in a timely, cost-efficient manner to address these aims: 1) To describe perceived and actual trends in drug market characteristics (e.g., purity, price, availability and formulations of heroin, meth and cocaine) and their relationship to drug use patterns in San Diego and Tijuana;2) To identify direct and indirect associations between specific drug market characteristics and negative medical consequences (e.g., soft tissue infections, overdose, mortality) among IDUs in both cities;3) To study trends in bi-directional cross-border mobility of IDUs in San Diego and Tijuana in relation to drug market characteristics, drug use patterns, involvement in the drug economy and intensity of border security;4) To compare specific drug market characteristics, drug use patterns, involvement in the drug economy, medical consequences of drug use and cross-border mobility among IDUs in San Diego and Tijuana, overall and in relation to social environmental influences (e.g., changes in policing and border security). To meet the proposed aims, we will recruit 600 IDUs (300 IDUs each from San Diego and Tijuana) aged 18 or older who have injected heroin, meth or cocaine in the last month using respondent driven sampling. IDUs will undergo interviews at baseline and at 6, 12, and 18 months. We will also obtain data on purity, price and availability of heroin, meth and cocaine from various external sources to triangulate perceived drug market trends from self-reports. To address Aims 3 and 4, we will also obtain records of U.S. border patrol line-watch hours for specific border sectors and systematically record counts of police activity/arrests at specific intersections over time in both cities. In meeting these aims, this study will identify important trends on retail drug markets, their antecedents and potential sequelae in the Mexico-U.S. border region during a period of intensified policing and border security. Given that northwestern Mexico represents a critical corridor through which illicit drugs enter the U.S., this study represents an unprecedented opportunity through which we can inform drug abuse prevention, treatment and drug policy in both the U.S. and Mexico.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DA024381-03
Application #
7671262
Study Section
Special Emphasis Panel (ZDA1-GXM-A (26))
Program Officer
Deeds, Bethany
Project Start
2007-09-25
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2011-08-31
Support Year
3
Fiscal Year
2009
Total Cost
$220,683
Indirect Cost
Name
University of California San Diego
Department
Family Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Strathdee, Steffanie A; Magis-Rodriguez, Carlos; Mays, Vickie M et al. (2012) The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol 22:426-38
Wagner, Karla D; Moynihan, Matthew J; Strathdee, Steffanie A et al. (2012) The social and environmental context of cross-border drug use in Mexico: findings from a mixed methods study of young injection drug users living in San Diego, CA. J Ethn Subst Abuse 11:362-78
Brouwer, Kimberly C; Lozada, Remedios; Weeks, John R et al. (2012) Intraurban mobility and its potential impact on the spread of blood-borne infections among drug injectors in Tijuana, Mexico. Subst Use Misuse 47:244-53
Volkmann, Tyson; Shin, Sanghyuk S; Garfein, Richard S et al. (2012) Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J Immigr Minor Health 14:281-6
Wagner, Karla D; Pollini, Robin A; Patterson, Thomas L et al. (2011) Cross-border drug injection relationships among injection drug users in Tijuana, Mexico. Drug Alcohol Depend 113:236-41
Moreno, José Guadalupe Bustamante; Licea, José Antonio Izazola; Ajenjo, Carlos Rodríguez (2010) Tackling HIV and drug addiction in Mexico. Lancet 376:493-5
Pollini, Robin A; Gallardo, Manuel; Hasan, Samreen et al. (2010) High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J Infect Dis 14 Suppl 3:e117-22
Deiss, Robert; Garfein, Richard S; Lozada, Remedios et al. (2009) Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health 99:1491-5
Volkow, Patricia; Brouwer, Kimberly C; Loza, Oralia et al. (2009) Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy 20:409-12
Pollini, Robin A; Alvelais, Jorge; Gallardo, Manuel et al. (2009) The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend 103:52-8

Showing the most recent 10 out of 13 publications